Maxcyte MXCT
NASDAQ MXCT
$1.20 +0.02 (+1.27%)
As of: Sep 30, 2026 · 12:15 PM EDT

Maxcyte (MXCT) Long-Term Debt Repayments (2021)

Updated

Maxcyte (MXCT) posted Long-Term Debt Repayments of $4.92 million for FY2021, up 241.8% from $1.44 million in FY2020.

Analysis

Maxcyte (MXCT) Long-Term Debt Repayments (2021) Analysis & Trends

  • Business Quant data shows MXCT's Long-Term Debt Repayments at $1.44 million in FY2020 (-71.8%) and $5.11 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn -
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 1.41 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn -
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn -
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn -
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn -
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn -
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 2.00 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn -
10 Maxcyte 123.12 Mn 123.12 Mn 5.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 4.92 Mn
API Access

Maxcyte Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=MXCT&period=max&api_key=YOUR_API_KEY